3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
28
Completed
25
Recruiting
5
Not yet recruiting
3
Terminated
2
Enrolling by invitation
1
Sponsor Class
OTHER
134
NIH
22
INDUSTRY
21
NETWORK
9
OTHER_GOV
2
INDIV
1
FED
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Kaposi
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Inflammatory Bowel Diseases
2
Head and Neck Neoplasms
2
HIV Infections
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Tract Infections
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Renal Insufficiency
1
Recurrence
1
Radiation Injuries
1
Prostatic Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Interventions
N-hydroxy-4-acetylaminostilbene
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
OTHER_GOV
×
Rectal Neoplasms
×
Clear all
NCT03402477
2024-04-24
NORWAIT
Helse Stavanger HF
Terminated
86 enrolled
NCT03170115
2020-12-17
ICAR
Instituto Nacional de Cancer, Brazil
Phase 2
Terminated
25 enrolled